
Zacks.com users have recently been watching Starbucks (SBUX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Starbucks Corporation is an American multinational chain of coffeehouses and roastery reserves headquartered in Seattle, Washington. As the world's largest coffeehouse chain, Starbucks is seen to be the main representation of the United States' second wave of coffee culture.
| Revenue (TTM) | $38.34B |
| Gross Profit (TTM) | $8.57B |
| EBITDA | $5.64B |
| Operating Margin | 12.90% |
| Return on Equity | 0.00% |
| Return on Assets | 8.02% |
| Revenue/Share (TTM) | $33.67 |
| Book Value | $-6.73 |
| Price-to-Book | 68.46 |
| Price-to-Sales (TTM) | 3.03 |
| EV/Revenue | 3.597 |
| EV/EBITDA | 26.03 |
| Quarterly Earnings Growth (YoY) | 85.70% |
| Quarterly Revenue Growth (YoY) | -1.40% |
| Shares Outstanding | $1.14B |
| Float | $1.14B |
| % Insiders | 0.13% |
| % Institutions | 87.17% |
Volatility is currently expanding

Zacks.com users have recently been watching Starbucks (SBUX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.

The public remains skeptical of the union bosses calling the shots in today's labor movement, a group claims.

The coffee chain's loyal tea drinkers are calling headquarters, emailing executives and signing petitions to try to get back their beloved chai formula.

The ruling is the latest by an appeals court to say that the NLRB went too far in finding workplace dress codes interfered with employees' rights to to advocate for better working conditions.

The turnaround is taking shape as sales accelerate.

SBUX's $1.8B debt paydown lowers leverage and financing costs, while strong liquidity and borrowing capacity likely reinforce financial flexibility.

SBUX gains an edge with stronger traffic, margin recovery and earnings revisions, while BROS faces cost and valuation pressure.

Pfizer and Starbucks both raised their outlooks this summer, but a louder recovery and a quieter one are not the same thing, and for investors who need a portfolio to fund actual withdrawals, the difference matters enormously.

Starbucks (SBUX) reported earnings 30 days ago. What's next for the stock?
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on SBUX and any ticker you trade — then tracks every position and per-strategy win rate.